The current and emerging role of immunotherapy in prostate cancer
about
Novel therapies for metastatic castrate-resistant prostate cancer.CD4+ T lymphocytes are critical mediators of tumor immunity to simian virus 40 large tumor antigen induced by vaccination with plasmid DNA.Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disordersInitial PSA oscillations precede prolonged stable disease in a patient treated with a therapeutic cancer vaccineOncolytic vaccines.Unleashing the therapeutic potential of human kallikrein-related serine proteases.HMGB1: A Promising Therapeutic Target for Prostate Cancer.
P2860
Q34249263-C2DD4D86-D9A6-4D83-A5FA-49640D1E3D53Q35077753-C58E86F1-5599-4E01-ACB5-4A126BEBC81DQ35738744-0C3C1FB5-B734-47C4-8A4F-261C366B0CC0Q35757242-DCD66E42-29DC-476D-BAF6-FD2588D1F96BQ38152474-900416EF-CB23-4191-801D-1D77750F0B6AQ38362486-B911C7B7-A427-4ACB-B5BD-0AB6C81ADE4FQ41136849-9E79ACBE-7D00-4D07-BD1F-F2EBCD7CD5A7
P2860
The current and emerging role of immunotherapy in prostate cancer
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
The current and emerging role of immunotherapy in prostate cancer
@ast
The current and emerging role of immunotherapy in prostate cancer
@en
type
label
The current and emerging role of immunotherapy in prostate cancer
@ast
The current and emerging role of immunotherapy in prostate cancer
@en
prefLabel
The current and emerging role of immunotherapy in prostate cancer
@ast
The current and emerging role of immunotherapy in prostate cancer
@en
P2860
P356
P1476
The current and emerging role of immunotherapy in prostate cancer
@en
P2093
James L Gulley
Ravi A Madan
P2860
P356
10.3816/CGC.2010.N.002
P407
P577
2010-12-01T00:00:00Z